Sepha deal to supply Novartis with leak inspection machines

Northern Ireland-based pharmaceutical engineering company, Sepha Ltd., has secured several significant new orders from pharmaceutical multinationals, in particular, Novartis, for its leak inspection machine, Visionscan.

Hp 20198 Sepha Visionscan

Visionscan is part of a new range of machines that use high-resolution imaging technology to detect product defects in pharmaceutical blister packs.

Since its launch last year, Sepha, has achieved export sales for Visionscan in all its major global markets including USA, Brazil, India, Europe, and New Zealand.

Paul Kelly, Head of Sales and Marketing said, "Over the last five years there have been considerable changes in global pharmaceutical production, with significant cost-saving measures implemented by most large drug producers. We developed our new range in response to these changes. Visionscan enables pharmaceutical manufacturers to significantly lower their production costs while at the same time improving their quality levels."

The machine, a mobile, leak-testing tabletop device, uses the latest camera imaging technology to offer a flexible and reliable cost-saving alternative to destructive blister pack test methods such as blue dye. It is easy to use and requires no tooling; for high-volume pharmaceutical manufacturers and packagers where high quality and cost control as well as multiple product changes are required. It can detect channel leaks and weak seals down to 15 micron and has a simple touchscreen operator interface.
Companies in this article
More in Home